Advertisement
Australia markets close in 2 hours 22 minutes
  • ALL ORDS

    7,790.10
    -108.80 (-1.38%)
     
  • ASX 200

    7,540.60
    -101.50 (-1.33%)
     
  • AUD/USD

    0.6390
    -0.0036 (-0.56%)
     
  • OIL

    84.69
    +1.96 (+2.37%)
     
  • GOLD

    2,405.70
    +7.70 (+0.32%)
     
  • Bitcoin AUD

    96,595.64
    -466.84 (-0.48%)
     
  • CMC Crypto 200

    1,278.88
    +393.35 (+42.84%)
     
  • AUD/EUR

    0.6005
    -0.0026 (-0.43%)
     
  • AUD/NZD

    1.0871
    -0.0004 (-0.03%)
     
  • NZX 50

    11,738.86
    -97.18 (-0.82%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,168.04
    -217.83 (-1.33%)
     
  • NIKKEI 225

    37,062.99
    -1,016.71 (-2.69%)
     

Monsanto still wants to buy Syngenta despite rejection

Swiss farm chemicals powerhouse Syngenta said Monsanto's takeover offer is "inadequate"

US agriculture and seed giant Monsanto restated its hope to acquire Syngenta Wednesday despite repeated rejections by the Swiss company, calling the deal the "logical next step for our business."

Monsanto said the deal is needed to create a company big enough to confront rising food demand due to population growth.

"Equipping farmers with the right set of innovations that will help solve tomorrow's food challenges today requires more than a new company -- it requires a new vision and approach," said Monsanto chief executive Hugh Grant.

Grant said a takeover of Syngenta provides "the opportunity to accelerate innovation and support a more diverse group of farmers around the world."

ADVERTISEMENT

Monsanto has bid 449 Swiss francs ($480) per share for Syngenta, representing a 35 percent premium from the previous day's closing price. The deal values Syngenta at about 42 billion Swiss francs ($45 billion).

But Syngenta has said Monsanto's offer is "inadequate" and argues that the US company has underestimated the scrutiny from antitrust regulators that would accompany a deal.

The Monsanto bid includes a $2 billion breakup fee if regulators block the deal, a sum Syngenta has called "wholly inadequate."

Monsanto reported net income of $1.1 billion for the quarter ending May 31, up 33 percent from the year-ago period.

Sales in seeds and genomics, Monsanto's biggest division, rose five percent to $3.2 billion.

Monsanto shares fell 0.7 percent to $112.04 in pre-market trade.